MATTHEW BOWERS: Open Payments
NPI 1215703657 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 15 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,318 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $99 |
| Vifor Pharma, Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| ABIOMED | 1 | $30 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
Products named: LOKELMA, LifeVest, Veltassa, JARDIANCE, ULTOMIRIS, TARPEYO, Wegovy, IBSRELA.
Industry payments across MI — which companies pay providers there.
